Published in Cancer Weekly, April 5th, 2005
The positive effects seen with once-daily AGILECT were similar to those seen in patients treated with entacapone, given with each levodopa dose, when compared to placebo. The results of the lasting effect in adjunct therapy with rasagiline given once daily (LARGO) study was published in The Lancet.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.